Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChAdOx1 nCoV-19 Vaccine in South African Adults
NCT04444674Phase 2Unknown
- Sponsor
- University of Oxford
- Start
- Jun 2020
- Primary completion
- Dec 2020
- Modality
- Viral Vector Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of ChAdOx1 nCoV-19 in coronavirus disease 2019 (COVID-19), sponsored by University of Oxford. Status: unknown.
02
Drugs
ChAdOx1 nCoV-19
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04444674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04444674.